Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of Propofol, Etomidate, and Thiopental on Seizure Parameters During Electroconvulsive Therapy
IRCT2017071135021N1Phase 3Completed
- Sponsor
- Golestan University of Medical Sciences
- Start
- Sep 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in seizure comparing Propofol, Etomidate and Thiopental (3 arms). Primary endpoint: Seizure duration during ECT. Started Sep 2017; status: completed.
02
Drugs
propofoletomidatethiopental
03
Conditions
seizure
Beyond the preview
Go deeper on IRCT2017071135021N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2017071135021N1.